Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease

Authors

Institutions

Publication Details

Journal
The Journal of Prevention of Alzheimer s Disease
Published
2025-10-18
DOI
https://doi.org/10.1016/j.tjpad.2025.100394
Citations
7
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
10.53
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease

Kausik Kumar Ray, Douglas Kling, Philip Scheltens, Jeffrey L. Cummings et al.
7 citations
The Journal of Prevention of Alzheimer s Disease
Computational Drug Discovery Methods
10.53
article

Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease

Kausik Kumar Ray, Douglas Kling, Philip Scheltens, Jeffrey L. Cummings, Danielle Curcio, Michael Szarek, John J.P. Kastelein, Marc Ditmarsch, Everard G.B. Vijverberg, Andrew Hsieh, Michael H Davidson, Stephen J Nicholls
article en
7 citations

Abstract

No abstract available for this paper.
The Journal of Prevention of Alzheimer s DiseaseVol. 13(1)
University of Nevada, Las Vegas (US), Korea Pharma (South Korea) (KR), Mount Sinai Hospital (US), Amsterdam Neuroscience (NL), Imperial College London (GB), Monash University (AU), University of Amsterdam (NL)
Openalex Percentile: Top 2%
Computational Drug Discovery Methods
10.53
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease — Kausik Kumar Ray, Douglas Kling, et al. · The Journal of Prevention of Alzheimer s Disease (2025) | TGRS Research Map | TGRS